BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7830014)

  • 21. Preliminary results of a district call scheme for cervical screening organised in general practice.
    Havelock CM; Webb J; Queenborough J
    BMJ; 1988 Nov; 297(6660):1384-6. PubMed ID: 3146374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the cervical cytology screening programme in an inner city health district.
    Beardow R; Oerton J; Victor C
    BMJ; 1989 Jul; 299(6691):98-100. PubMed ID: 2504348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer prevention in primary care. Screening for cervical cancer.
    Austoker J
    BMJ; 1994 Jul; 309(6949):241-8. PubMed ID: 7980803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting uptake of cervical and breast cancer screening among perimenopausal women in Hong Kong.
    Chan C; Ho SC; Chan SG; Yip YB; Wong FC; Cheng F
    Hong Kong Med J; 2002 Oct; 8(5):334-41. PubMed ID: 12376710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Consequences of incorrect interpretation of vaginal smear tests in a screening program].
    Lynge E; Arffmann E; Poll P; Andersen PK
    Ugeskr Laeger; 1994 Apr; 156(17):2594-6. PubMed ID: 8016968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six years' audit of laboratory workload and rates of referral for colposcopy in a cervical screening programme in three districts.
    Raffle AE; Alden B; Mackenzie EF
    BMJ; 1990 Oct; 301(6757):907-11. PubMed ID: 2261537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for cervical cancer by general practitioners in Ghent, Belgium.
    De Schryver A; Derese A; Geldhof A; Vuylsteek K
    Cancer Detect Prev; 1989; 13(5-6):343-8. PubMed ID: 2743357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs and remuneration for cervical screening in general practice in the west of Scotland.
    Myles S; Wyke S; Ibbotson T; Macintyre S; McEwen J; Kelly M
    J Health Serv Res Policy; 1996 Oct; 1(4):217-23. PubMed ID: 10180874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Have the most recent Pap smear guidelines affected GP practices?
    Wai D; Ferrier A; Collings S; Laverty C
    Aust Fam Physician; 1996 Jan; Suppl 1():S44-8. PubMed ID: 9479800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective randomised controlled trial of methods of call and recall for cervical cytology screening.
    Pierce M; Lundy S; Palanisamy A; Winning S; King J
    BMJ; 1989 Jul; 299(6692):160-2. PubMed ID: 2504359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problems of cervical cancer screening programmes.
    Rang EH; Tod ED
    J R Coll Gen Pract; 1988 Jun; 38(311):267-9. PubMed ID: 3255814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for stopping cervical screening in women over 50.
    Van Wijngaarden WJ; Duncan ID
    BMJ; 1993 Apr; 306(6883):967-71. PubMed ID: 8490472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing women's compliance with opportunistic cervical cancer screening: a randomized trial.
    Ward JE; Boyle K; Redman S; Sanson-Fisher RW
    Am J Prev Med; 1991; 7(5):285-91. PubMed ID: 1790034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal cervical smear test results: old dilemmas and new directions.
    Wilkinson C
    Br J Gen Pract; 1992 Aug; 42(361):336-9. PubMed ID: 1457156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical smears: comparison of knowledge and practice of a general practice sample with a high-risk group.
    ní Riain A; Stewart M; Phelan D; Bury G; Mulcahy F
    Int J STD AIDS; 2001 Mar; 12(3):171-5. PubMed ID: 11231870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can an appointment-letter intervention increase pap smear screening in Samliem, Khon Kaen, Thailand?
    Chumworathayi B; Yuenyao P; Luanratanakorn S; Pattamadilok J; Chalapati W; Na-Nhongkai C
    Asian Pac J Cancer Prev; 2007; 8(3):353-6. PubMed ID: 18159966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the CSEU cervical screening cohort study.
    Blanks RG; Moss SM; Coleman DA; Swerdlow AJ
    BJOG; 2007 Nov; 114(11):1408-13. PubMed ID: 17803716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.